Amgen shares climbed nearly 6% on Oct. 11, their biggest single-day gain in seven months, behind a rating bump from a Morgan Stanley analyst, and continued to climb more gradually in the days after. Thousand Oaks-based Amgen, one of the largest biotechnology companies in the world, closed at $245.44 on Oct. 11, up from $232.15…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
